Avelumab is a type of immunotherapy known as a monoclonal antibody. It is designed to help the immune system detect and fight cancer cells. Specifically, avelumab targets and inhibits the PD-L1 protein, a mechanism that tumors use to evade the immune response. By blocking PD-L1, avelumab helps to restore the immune system's ability to identify and destroy cancer cells.
